Bio Essence Corporation
BIOE
$0.215
-$0.0201-8.55%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 223.02% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 223.02% | -- | |||
| Cost of Revenue | 329.60% | -- | |||
| Gross Profit | 177.40% | -- | |||
| SG&A Expenses | 17.10% | 27.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.80% | 68.64% | |||
| Operating Income | 31.68% | -41.17% | |||
| Income Before Tax | -458.17% | -74.72% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -456.10% | -75.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -456.10% | -261.09% | |||
| EBIT | 31.68% | -41.17% | |||
| EBITDA | 31.59% | -41.44% | |||
| EPS Basic | -454.39% | -262.86% | |||
| Normalized Basic EPS | 31.43% | -75.00% | |||
| EPS Diluted | -454.39% | -262.86% | |||
| Normalized Diluted EPS | 31.43% | -75.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
